Goat Anti-Rat IgG H&L (DyLight® 488) (ab96887)
Key features and details
- Goat Anti-Rat IgG H&L (DyLight® 488)
- Conjugation: DyLight® 488. Ex: 493nm, Em: 518nm
- Host species: Goat
- Isotype: IgG
- Suitable for: IHC-P, ICC/IF, Flow Cyt
製品の概要
-
製品名
Goat Anti-Rat IgG H&L (DyLight® 488)
IgG 二次抗体 製品一覧 -
由来種
Goat -
ターゲット生物種
Rat -
特異性
By immunoelectrophoresis and ELISA this antibody reacts specifically with Rat IgG and with light chains common to other Rat immunoglobulins. No antibody was detected against non-immunoglobulin serum proteins. -
アプリケーション
適用あり: IHC-P, ICC/IF, Flow Cytmore details -
標識
DyLight® 488. Ex: 493nm, Em: 518nm
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C. -
バッファー
pH: 6.8
Preservative: 0.09% Sodium azide
Constituents: 0.2% BSA, PBS -
Concentration information loading...
-
精製度
Immunogen affinity purified -
特記事項(精製)
This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to DyLight® 488. -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab96887の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
IHC-P |
1/50 - 1/500.
|
|
ICC/IF |
1/50 - 1/500.
|
|
Flow Cyt |
1/50 - 1/200.
|
特記事項 |
---|
IHC-P
1/50 - 1/500. |
ICC/IF
1/50 - 1/500. |
Flow Cyt
1/50 - 1/200. |
画像
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
Datasheet download
参考文献 (7)
ab96887 は 7 報の論文で使用されています。
- Castellanos-Montiel MJ et al. An Optimized Workflow to Generate and Characterize iPSC-Derived Motor Neuron (MN) Spheroids. Cells 12:N/A (2023). PubMed: 36831212
- Linzey M et al. Divergent complement system activation in two clinically distinct murine models of multiple sclerosis. Front Immunol 13:924734 (2022). PubMed: 35958570
- Zhang I et al. Nanotherapeutic Modulation of Human Neural Cells and Glioblastoma in Organoids and Monocultures. Cells 9:N/A (2020). PubMed: 33171886
- Ireland L et al. Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer. Oncogene 37:2022-2036 (2018). IHC-P . PubMed: 29367764
- Kulshrestha A et al. Selective inhibition of tumor cell associated Vacuolar-ATPase 'a2' isoform overcomes cisplatin resistance in ovarian cancer cells. Mol Oncol 10:789-805 (2016). PubMed: 26899534
- Jones CI et al. RNA-seq reveals post-transcriptional regulation of Drosophila insulin-like peptide dilp8 and the neuropeptide-like precursor Nplp2 by the exoribonuclease Pacman/XRN1. Nucleic Acids Res 44:267-80 (2016). ICC/IF . PubMed: 26656493
- Lundholm L et al. Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest. Cell Death Dis 4:e478 (2013). Flow Cyt ; Human . PubMed: 23370278